The Journal of Urology
Volume 181, Issue 3 , Pages 1361-1371, March 2009

Response of Bladder Carcinoma Cells to TRAIL and Antisense Oligonucleotide, Bcl-2 or Clusterin Treatments

  • Bo Sun

      Affiliations

    • Department of Surgery, Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada
    • ,
  • Jacob A. Moibi

      Affiliations

    • Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada
    • ,
  • Allan Mak

      Affiliations

    • Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada
    • ,
  • Zhengwen Xiao

      Affiliations

    • Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada
    • ,
  • Wilson Roa

      Affiliations

    • Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada
    • ,
  • Ronald B. Moore

      Affiliations

    • Department of Surgery, Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada
    • Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada
    • Corresponding Author InformationCorrespondence: Department of Surgery, University of Alberta, 2D2.16 Walter Mackenzie Health Sciences Centre, 8440 112 St., Edmonton, Alberta, Canada T6G 2B7 (telephone: 780-407-6330; FAX: 780-407-6331)
    • Financial interest and/or other relationship with Quest Pharmatech and Nat Immune.

Received 18 July 2008 published online 20 January 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Supported by the Canadian Cancer Society through National Cancer Institute of Canada Grant 15105.

PII: S0022-5347(08)02996-0

doi:10.1016/j.juro.2008.10.148

The Journal of Urology
Volume 181, Issue 3 , Pages 1361-1371, March 2009

Article Tools

* Image Usage & Resolution